Arabic Arabic English English French French German German
dark

Protara Therapeutics Announces Results from a Retrospective Study Evaluating the Prevalence of Cholestasis in Patients Dependent on Parenteral Nutrition

Protara Therapeutics, Inc. today announced the completion of a retrospective prevalence study designed to enhance understanding of the incidence of intestinal failure associated liver disease (IFALD) in patients dependent on parenteral nutrition (PN). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

ClearDATA Partners with Interlace Health to Safeguard Data for Zero-Touch Patient Intake Solution

Next Post

Transgene Announces Upcoming Investor Meetings – Sep 13, 2021

Related Posts
Total
0
Share